Rep. Henry Waxman - 29th District of California

About Rep. Waxman
Issues and Legislation
In the News
Constituent Services
The 29th District
About Congress
Contact Us

In Washington, D.C.
2204 Rayburn House Office Building
Washington, D.C. 20515
(202) 225-3976 (phone)
(202) 225-4099 (fax)

In Los Angeles
8436 West Third Street, Suite 600
Los Angeles, CA 90048
(323) 651-1040 (phone) (818) 878-7400 (phone) (310) 652-3095 (phone) (323) 655-0502 (fax)

Send a Message to Rep. Waxman


In the News

Letters

Rezulin

Letters | Press Accounts | Links

Statements and Letters

February 25, 1999
Letter from FDA Associate Commissioner Diane Thompson
Response to Safety Questions

February 19, 1999
Letter from NIH Director Dr. Harold Varmus
Preliminary findings from the investigation into outside activities of senior NIH staff

December 29, 1998
Letter from NIH Director Dr. Harold Varmus
Responding to Rep. Waxman´s December 7 letter to the NIH.

December 18, 1998
Letter to FDA Commissioner Dr. Jane Henney
Requesting answers to several questions about the safety of Rezulin and its approval process.

December 7, 1998
Letter to NIH Director Dr. Harold Varmus
Requesting that the NIH investigate the potential c
onflict of interest with Dr. Eastman´s dual affiliation with the NIH and Warner-Lambert